Press Releases

Date	Title and Summary	Additional Formats
April 26, 2023	Vericel to Report First-Quarter 2023 Financial Results on May 10, 2023	View HTML PDF Version
February 28, 2023	Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 7, 2023	View HTML PDF Version
February 23, 2023	Vericel Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Full-Year 2023 Financial Guidance	View HTML PDF Version
February 9, 2023	Vericel to Report Fourth-Quarter 2022 Financial Results on February 23, 2023	View HTML PDF Version
January 10, 2023	Vericel Announces Preliminary Fourth-Quarter and Full-Year 2022 Financial Results and Accelerated Launch Timeline for MACI Arthroscopic Program	View HTML PDF Version
January 4, 2023	Vericel to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023	View HTML PDF Version
December 29, 2022	Vericel Announces FDA Approval of NexoBrid for the Treatment of Severe Thermal Burns in Adults	View HTML PDF Version
November 10, 2022	Vericel to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health & Service Forum and the Stephens Annual Investment Conference	View HTML PDF Version
November 9, 2022	Vericel Reports Third Quarter 2022 Financial Results	View HTML PDF Version
October 26, 2022	Vericel to Report Third-Quarter 2022 Financial Results on November 9, 2022	View HTML PDF Version

Investor Relations